FDA is accelerating and modernizing clinical research across the full continuum of drug development
Through Operation TrialBlazer, a U.S. Department of Health and Human Services Initiative, the FDA is eliminating unnecessary regulatory burden, clarifying phase-appropriate requirements, and building partnerships with government, academic medical centers, and the private sector.
